» Articles » PMID: 37085762

Exosomal MicroRNA-342-5p Secreted from Adipose-derived Mesenchymal Stem Cells Mitigates Acute Kidney Injury in Sepsis Mice by Inhibiting TLR9

Overview
Publisher Biomed Central
Date 2023 Apr 21
PMID 37085762
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sepsis-related acute kidney injury (AKI) is an inflammatory disease associated with extremely high mortality and health burden. This study explored the possibility of exosomes secreted by adipose-derived mesenchymal stem cells (AMSCs) serving as a carrier for microRNA (miR)-342-5p to alleviate sepsis-related AKI and investigated the possible mechanism.

Methods: Serum was obtained from 30 patients with sepsis-associated AKI and 30 healthy volunteers for the measurement of miR-342-5p, blood urea nitrogen (BUN), and serum creatinine (SCr) levels. For in vitro experiments, AMSCs were transfected with LV-miR-342-5p or LV-miR-67 to acquire miR-342-5p-modified AMSCs and miR-67-modified AMSCs, from which the exosomes (AMSC-Exo-342 and AMSC-Exo-67) were isolated. The human renal proximal tubular epithelial cell line HK-2 was induced by lipopolysaccharide (LPS) to construct a cellular model of sepsis. The expression of Toll-like receptor 9 (TLR9) was also detected in AKI cells and mouse models. The interaction between miR-342-5p and TLR9 was predicted by dual luciferase reporter gene assay.

Results: Detection on clinical serum samples showed that BUN, SCr, and TLR9 were elevated and miR-342-5p level was suppressed in the serum of patients with sepsis-associated AKI. Transfection with LV-miR-342-5p reinforced miR-342-5p expression in AMSCs and AMSC-secreted exosomes. miR-342-5p negatively targeted TLR9. LPS treatment enhanced TLR9 expression, reduced miR-342-5p levels, suppressed autophagy, and increased inflammation in HK-2 cells, while the opposite trends were observed in LPS-induced HK-2 cells exposed to AMSC-Exo-342, Rapa, miR-342-5p mimic, or si-TLR9. Additionally, the effects of AMSC-Exo-342 on autophagy and inflammation in LPS-induced cells could be weakened by 3-MA or pcDNA3.1-TLR9 treatment. Injection of AMSC-Exo-342 enhanced autophagy, mitigated kidney injury, suppressed inflammation, and reduced BUN and SCr levels in sepsis-related AKI mouse models.

Conclusion: miR-342-5p transferred by exosomes from miR-342-5p-modified AMSCs ameliorated AKI by inhibiting TLR9 to accelerate autophagy.

Citing Articles

Analysis of key microRNA molecules associated with acute kidney injury based on bioinformatics method.

Liu D, Zhang X, Xu J, Chen C, Shao H, Chen X Medicine (Baltimore). 2025; 104(10):e41785.

PMID: 40068024 PMC: 11902973. DOI: 10.1097/MD.0000000000041785.


Emerging Frontiers in acute kidney injury: The role of extracellular vesicles.

Li S, Zhou L, Huang Y, Tang S Bioact Mater. 2025; 48:149-170.

PMID: 40046015 PMC: 11880721. DOI: 10.1016/j.bioactmat.2025.02.018.


Study on the diagnostic role of exosome-derived miRNAs in postoperative septic shock and non-septic shock patients.

Garcia-Concejo A, Sanchez-Quiros B, Gomez-Sanchez E, Sanchez-de Prada L, Tamayo-Velasco A, Tovar-Doncel M Crit Care. 2025; 29(1):96.

PMID: 40033446 PMC: 11874436. DOI: 10.1186/s13054-025-05320-y.


Exosome-based therapies for inflammatory disorders: a review of recent advances.

Saleem M, Shahzad K, Marryum M, Singh S, Zhou Q, Du S Stem Cell Res Ther. 2024; 15(1):477.

PMID: 39695750 PMC: 11657721. DOI: 10.1186/s13287-024-04107-2.


Macrophage-derived extracellular vesicles from antigen exposure enhance growth control, reduce IL-1β, and contain miR-342-5p, miR-516b-5p, and miR-570-3p that regulate PI3K/AKT and MAPK signaling pathways.

Pushpamithran G, Blomgran R Front Immunol. 2024; 15:1454881.

PMID: 39569198 PMC: 11576181. DOI: 10.3389/fimmu.2024.1454881.


References
1.
Tsuji K, Kitamura S, Wada J . Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity. Stem Cells Int. 2019; 2018:8693137. PMC: 6311717. DOI: 10.1155/2018/8693137. View

2.
Poston J, Koyner J . Sepsis associated acute kidney injury. BMJ. 2019; 364:k4891. PMC: 6890472. DOI: 10.1136/bmj.k4891. View

3.
Zou G, Zhou Z, Xi X, Huang R, Hu H . Pioglitazone Ameliorates Renal Ischemia-Reperfusion Injury Inhibition of NF-κB Activation and Inflammation in Rats. Front Physiol. 2021; 12:707344. PMC: 8326914. DOI: 10.3389/fphys.2021.707344. View

4.
Zhang W, Zhang J, Huang H . Exosomes from adipose-derived stem cells inhibit inflammation and oxidative stress in LPS-acute kidney injury. Exp Cell Res. 2022; 420(1):113332. DOI: 10.1016/j.yexcr.2022.113332. View

5.
Huang X, Ding J, Li Y, Liu W, Ji J, Wang H . Exosomes derived from PEDF modified adipose-derived mesenchymal stem cells ameliorate cerebral ischemia-reperfusion injury by regulation of autophagy and apoptosis. Exp Cell Res. 2018; 371(1):269-277. DOI: 10.1016/j.yexcr.2018.08.021. View